Application of Economics & Social Psychology to Improve Opioid Prescribing Safety (AESOPS): R21 Pilot Phase

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 25, 2019

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Opioid Use, Unspecified
Interventions
BEHAVIORAL

Opioid naive

Visit where the order is for an included opioid and there is no prior opioid prescription with a start date of greater than 1 day and less than 91 days

BEHAVIORAL

At-risk for long term use

Visit where the order is for an included opioid, there is a prior opioid prescription with a start date greater than 1 day and less than 91 days, and there is no prior opioid prescription with a start date greater than 90 days

BEHAVIORAL

Long-term opioid recipient

Total opioid doses are at least 50 MME per day, there are two or more prior opioid prescriptions with two different start dates both greater than 1 day and less than 91 days, and there is a prior opioid prescription with a start date greater than 90 days and less than 181 days

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

Northwestern University

OTHER

collaborator

AltaMed Health Services Corporation

OTHER

collaborator

The Children's Clinic

OTHER

lead

University of Southern California

OTHER

NCT03773484 - Application of Economics & Social Psychology to Improve Opioid Prescribing Safety (AESOPS): R21 Pilot Phase | Biotech Hunter | Biotech Hunter